如果您经历了频繁的头痛发作,影响了工作、学习和日常生活,那么艾普奈珠单抗(eptinezumab)可能适合您。 2. 对其他药物治疗无效或不能耐受:如果您已经尝试了其他常规的偏头痛治疗药物,但效果不佳或出现明显的不良反应,艾普奈珠单抗(eptinezumab)可能是一个可行的选择。 4. 使用注意事项 在使用艾普奈珠单抗(epti...
VYEPTI is contraindicated in patients with serious hypersensitivity to eptinezumab-jjmr or to any of the excipients. Reactions have included anaphylaxis and angioedema. WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Hypersensitivity reactions, including angioedema, urticaria, facial flushing, dyspnea, ...
艾普奈珠单抗的适应症有哪些,艾普奈珠单抗(eptinezumab)是一种专门针对偏头痛发病机制而开发的新型药物,其适应证是成人偏头痛的预防性治疗。艾普奈珠单抗(eptinezumab)是一种针对特定靶点的单克隆抗体,主要用于预防偏头痛的治疗。近年来,这种药物因其独特的作用机制和良好的临床效果逐渐受到关注。此外,艾普奈珠单抗在...
Intermittent Infusion: Dilution: For 100 mg dose, withdraw 1 mL eptinezumab and dilute in 100 mL 0.9% NaCl. For 300 mg dose, withdraw 1 mL eptinezumab from each of 3 vials and dilute in 100 mL 0.9% NaCl. Gently invert to mix; do not shake. Infusion bags must be made of pol...
Vyepti - 艾普奈珠单抗(Eptinezumab)的规格 1. 高效剂量抗体 艾普奈珠单抗属于单克隆抗体类药物。每次使用Vyepti,患者会接受到一个高效剂量的艾普奈珠单抗注射,该剂量能长时间保持在治疗水平。这一特点使Vyepti在预防偏头痛发作方面具有突出的效果。 2. 长效作用 Vyepti的治疗效果可持续数月。一次注射后...
Eptinezumab side effects Get emergency medical help if you havesigns of an allergic reaction:hives,rash; sudden warmth or tingling; difficult breathing; redness or swelling of your face, lips, tongue, or throat. Some side effects may occur during the injection. Tell your caregiver if you feel...
IMPORTANT SAFETY INFORMATION Do not receive VYEPTI if you have a known allergy to eptinezumab-jjmr or its ingredients. VYEPTI may cause allergic reactions. Call your healthcare provider or get emergency medical help right away if you have any symptoms of an allergic reaction: rash; swelling...
Eptinezumab (Vyepti) is a new CGRP monoclonal antibody for migraine prophylaxis that is administered by intravenous infusion. This article discusses its place in therapy, clinical trial efficacy and adverse effects.John Wiley & Sons, IncPrescriber...
艾普奈珠单抗(Eptinezumab)是一种针对偏头痛的新一代治疗药物,其中的主要成分就是艾普奈珠单抗(Eptinezumab)。艾普奈珠单抗是一种单克隆抗体,被商业名称Vyepti所使用。它通过靶向特定的蛋白质减少偏头痛的发作次数和疼痛的程度,从而为患者提供可靠的缓解。 1. 艾普奈珠单抗(eptinezumab):有效靶向偏头痛 艾普奈...
4.4 Eptinezumab The results of Eptinezumab in patients with EM (known as PROMISE-1) has recently been published (Ashina et al., 2020). In this trial, a total of 888 patients were assigned to receive quarterly intravenous injection of eptinezumab 30 mg, 100 and 300 mg and placebo. ...